US HB2276 | 2011-2012 | 112th Congress
Status
Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on June 22 2011 - 25% progression, died in committee
Action: 2011-08-25 - Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
Pending: House Subcommittee on Intellectual Property, Competition and the Internet Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 22 2011 - 25% progression, died in committee
Action: 2011-08-25 - Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
Pending: House Subcommittee on Intellectual Property, Competition and the Internet Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Directs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) to: (1) study ways to provide independent, confirming genetic diagnostic test activity where gene patents and exclusive licensing for primary genetic diagnostic tests exist; and (2) report the findings to Congress within nine months along with recommendations for establishing the availability of such independent confirming genetic diagnostic test activity. Defines confirming genetic diagnostic test activity as the performance of a genetic diagnostic test, by a genetic diagnostic test provider, on an individual solely for the purpose of providing the individual with an independent confirmation of results obtained from another test providers prior performance of the test on the individual.
Title
To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2011-08-25 | House | Referred to the Subcommittee on Intellectual Property, Competition and the Internet. |
| 2011-06-22 | House | Referred to the Subcommittee on Health. |
| 2011-06-22 | House | Referred to House Energy and Commerce |
| 2011-06-22 | House | Referred to House Judiciary |
| 2011-06-22 | House | Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Same As/Similar To
HB1249 (Related) 2011-09-16 - Became Public Law No: 112-29.
Subjects
Commerce
Congressional oversight
Genetics
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Health care quality
Intellectual property
Medical tests and diagnostic methods
Congressional oversight
Genetics
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Health care quality
Intellectual property
Medical tests and diagnostic methods
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/112th-congress/house-bill/2276/all-info |
| Text | https://www.congress.gov/112/bills/hr2276/BILLS-112hr2276ih.pdf |
